Google Maps

NCT07730567

Overview

NCT ID: NCT07730567
Lead Sponsor: Addpharma Inc.INDUSTRY
Official Title: A Two-arm, Open-label, Single-sequence, Multiple-dose Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B in Healthy Adult Volunteers
Brief Summary: To evaluate the pharmacokinetic interaction and the safety of AD-236A and AD-236B in healthy adult volunteers
Conditions: Hyperlipidemia
Diabete Type 2
Interventions: Treatment A(AD-236A)
Treatment B(AD-236B)
Treatment C(AD-236A+AD-236B)

Ages Eligible for Study: Adult (18-64)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: Yes
Eligibility Criteria: Inclusion Criteria:

Healthy adult volunteers aged ≥19 and ≤55 years at the time of the screening visit

Body weight ≥50 kg (≥45 kg for females) and body mass index (BMI) between 18.0 kg/m² and 30.0 kg/m² at the time of the screening visit

Exclusion Criteria:

Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration

Other exclusions applied